|
Metabolites (umol/L)
|
NM
|
MUCO
|
MHPO
|
P1
|
P2
|
P3
|
|---|
|
Leucine
|
189.5 ± 37.6
|
321.5 ± 36.8
|
216.6 ± 32.6
|
0.000
|
0.346
|
0.000
|
|
Isoleucine
|
87.7 ± 48.2
|
132.0 ± 52.7
|
92.5 ± 45.2
|
0.000
|
0.584
|
0.000
|
|
Valine
|
297.8 ± 50.1
|
388.5 ± 53.4
|
291.3 ± 43.4
|
0.000
|
0.917
|
0.000
|
|
alphaAAA
|
2.45 ± 0.24
|
3.10 ± 0.40
|
2.62 ± 0.29
|
0.000
|
0.138
|
0.000
|
|
C3
|
0.30 ± 0.08
|
0.42 ± 0.11
|
0.29 ± 0.11
|
0.000
|
0.976
|
0.000
|
- All values are means ± SDs. The One-Way ANOVA followed by Tukey test was set to p < 0.05. NW normal weight, MUCO metabolically unhealthy central obesity, MHPO metabolically healthy peripheral obesity; alphaAAA, alpha-aminoadipic acid. Logarithmic transformation was used for the variables that did not have normal distribution (alphaAAA); P1: The P value between MUCO and NW groups; P2: The P value between MHPO and NW groups; P3:The P value between MUPO and MHPO groups
